{"path":"Images/Pasted image 20240201141315.png","text":"ailoring of BP, cardiac risk assessment Management of HF k. Hyp.K*->calcium salts ESA, transfusion, Cardiovascular dysfunction ~ Adequate solution Prevention of monitoring alloimmunization U 1 €L i Electrolyte and Renal anemia ¢, =7 metabolic disorders — = Pharmacologic issue Coagulopathy T ﬂ T Appropriate drug choice Transfusion, ESA, Disturbance of equilibrium Heparin-free HD, T discontinuation of Goal-directed therapy (SVV, Scvo,) ~ antiplatelet Appropriate solution for fluid therapy Medication","libVersion":"0.3.2","langs":"eng"}